title: Altered growth phenotype of a Burkitt's lymphoma line following the introduction and stable expression of the EBNA 2A gene.
authors.forename: J
authors.initials: J
authors.lastname: Gordon
authors.forename: M J
authors.initials: MJ
authors.lastname: Millsum
authors.forename: M
authors.initials: M
authors.lastname: Finney
authors.forename: J A
authors.initials: JA
authors.lastname: Cairns
authors.forename: G R
authors.initials: GR
authors.lastname: Guy
authors.forename: C D
authors.initials: CD
authors.lastname: Gregory
authors.forename: S D
authors.initials: SD
authors.lastname: Abbot
authors.forename: A B
authors.initials: AB
authors.lastname: Rickinson
authors.forename: F
authors.initials: F
authors.lastname: Wang
authors.forename: E
authors.initials: E
authors.lastname: Kieff
mesh_terms: D000956:Antigens, Viral / Q000235:genetics; D002051:Burkitt Lymphoma / Q000209:etiology* / Q000473:pathology; D019309:Epstein-Barr Virus Nuclear Antigens; D005814:Genes, Viral; D006801:Humans; D010641:Phenotype; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000473:pathology
chemical_list: D000956:Antigens, Viral; D019309:Epstein-Barr Virus Nuclear Antigens; D013755:Tetradecanoylphorbol Acetate